Research progress of optical coherence tomography and optical coherence tomography angiography in thyroid-associated ophthalmopathy
Author:
Fund Project:

National Natural Science Foundation of China(No.82071005)

  • Article
  • | |
  • Metrics
  • |
  • Reference [49]
  • |
  • Related [20]
  • | | |
  • Comments
    Abstract:

    Thyroid-associated ophthalmopathy(TAO)is the most common orbital disease in adults, characterized by inflammatory cell infiltration in the retrobulbar and periorbital soft tissues. This condition induces a series of pathological alterations including enlargement of the extraocular muscles, increased retrobulbar adipose tissue, soft tissue edema, and orbital fibrosis, resulting in elevated intraorbital pressure and impeded venous return, and in severe cases, can cause dysthyroid optic neuropathy(DON), which is one of the main causes of vision loss in patients. There are abnormalities in ocular hemodynamics in TAO patients, and the occurrence of DON is closely related to optic nerve ischemia. Therefore, it may be important to understand and monitor changes in ocular blood flow in TAO patients as early as possible. Optical coherence tomography(OCT)and optical coherence tomography angiography(OCTA)can obtain in vivo images of retinal and choroidal tissue structure and vasculature with non-contact, non-invasive, rapid, and high-resolution characteristics. They have been used to study changes in ocular blood flow in a variety of ophthalmic and systemic diseases. To date, a multitude of scholars have employed OCT and OCTA to investigate the microcirculatory structure and blood flow in the fundus of patients with TAO. However, the research results are still controversial due to differences in measurement techniques, confounding factors, and study populations, and there is no relevant domestic literature review in this field. This article reviews the research progress of OCT and OCTA in TAO, thus exploring the application value of OCT and OCTA technology in TAO.

    Reference
    \〖1\〗 Hai YP, Lee ACH, Chen K, et al. Traditional Chinese medicine in thyroid-associated orbitopathy. J Endocrinol Invest, 2023,46(6):1103-1113.
    \〖2\〗 Bartalena L, Piantanida E, Gallo D, et al. Epidemiology, natural history, risk factors, and prevention of Graves' orbitopathy. Front Endocrinol, 2020,11:615993.
    \〖3\〗 Dolman PJ. Dysthyroid optic neuropathy: evaluation and management. J Endocrinol Invest, 2021,44(3):421-429.
    \〖4\〗 Goel R, Shah S, Gupta S, et al. Alterations in retrobulbar haemodynamics in thyroid eye disease. Eye, 2023,37(17):3682-3690.
    \〖5\〗 Di Y, Ye JJ. Application of optical coherence tomography angiography in ophthalmology. Zhonghua Yan Ke Za Zhi, 2017,53(1):65-72.
    \〖6\〗 Yan YJ, Zhang L, Wang ZJ, et al. Clinical observation on the evolution process of macular ganglion cell complex and peripapillary retinal nerve fiber layer of neuritis patients. Zhonghua Yan Ke Za Zhi, 2018,54(1):62-68.
    \〖7\〗 Wu Y, Tu Y, Wu C, et al. Reduced macular inner retinal thickness and microvascular density in the early stage of patients with dysthyroid optic neuropathy. Eye Vis(Lond), 2020, 7: 16.
    \〖8\〗 Tu Y, Jin H, Xu M, et al. Reduced contrast sensitivity function correlated with superficial retinal capillary plexus impairment in early stage of dysthyroid optic neuropathy. Eye Vis(Lond), 2023, 10(1): 11.
    \〖9\〗 Jamshidian Tehrani M, Mahdizad Z, Kasaei A, et al. Early macular and peripapillary vasculature dropout in active thyroid eye disease. Graefes Arch Clin Exp Ophthalmol, 2019, 257(11): 2533-2540.
    \〖10\〗 Wu JH, Luo LY, Zhou H, et al. Reduced choroidal peripapillary capillaries in thyroid-associated ophthalmopathy with early stage of dysthyroid optic neuropathy. Int J Ophthalmol, 2022,15(7):1135-1141.
    \〖11\〗 Kurt MM, Akpolat C, Evliyaoglu F, et al. Evaluation of retinal neurodegeneration and choroidal thickness in patients with inactive Graves' ophthalmopathy. Klin Monbl Augenheilkd, 2021,238(7):797-802.
    \〖12\〗 Sayın O, Yeter V, Arıtürk N. Optic disc, macula, and retinal nerve fiber layer measurements obtained by OCT in thyroid-associated ophthalmopathy. J Ophthalmol, 2016,2016:9452687.
    \〖13\〗 Jian H, Wang Y, Ou L, et al. Altered peripapillary vessel density and nerve fiber layer thickness in thyroid-associated ophthalmopathy using optical coherence tomography angiography. Int Ophthalmol, 2022, 42(3): 855-862.
    \〖14\〗 Zhu P, Liu Z, Lu Y, et al. Alterations in Spontaneous Neuronal Activity and Microvascular Density of the Optic Nerve Head in Active Thyroid-Associated Ophthalmopathy. Front Endocrinol(Lausanne), 2022, 13: 895186.
    \〖15\〗 Ceylanoglu KS, Eser NA, Sen EM. Choroidal structural evaluation in inactive Graves' ophthalmopathy. Photodiagnosis Photodyn Ther, 2022,39:103012.
    \〖16\〗 Wu Y, Yang Q, Ding L, et al. Peripapillary structural and microvascular alterations in early dysthyroid optic neuropathy. Eye Vis(Lond), 2022, 9(1): 30.
    \〖17\〗 Zeng P, Wang J, Tian P, et al. Macular and peripapillary optical coherence tomography angiography metrics in thyroid-associated ophthalmopathy with chorioretinal folds. Photodiagnosis Photodyn Ther, 2023,42:103146.
    \〖18\〗 McKeag D, Lane C, Lazarus JH, et al. Clinical features of dysthyroid optic neuropathy: a European Group on Graves' Orbitopathy(EUGOGO)survey. Br J Ophthalmol, 2007,91(4):455-458.
    \〖19\〗 Sener H, Ozer F, Unlu M, et al. Automated evaluation of parapapillary choroidal microvasculature in thyroid eye disease. Int Ophthalmol, 2023,43(11):4323-4331.
    \〖20\〗 Xu B, Wang S, Chen L, et al. The early diagnostic value of optical coherence tomography(OCT)and OCT angiography in thyroid-associated ophthalmopathy. Ther Adv Chronic Dis, 2023,14:20406223231166802.
    \〖21\〗 Delaey C, Van De Voorde J. Regulatory mechanisms in the retinal and choroidal circulation. Ophthalmic Res, 2000, 32(6): 249-256.
    \〖22\〗 Ostrin LA, Harb E, Nickla DL, et al. IMI-The Dynamic Choroid: New Insights, Challenges, and Potential Significance for Human Myopia. Invest Ophthalmol Vis Sci, 2023, 64(6): 4.
    \〖23\〗 Özkan B, Koçer ÇA, Altinta瘙塂 Ö, et al. Choroidal changes observed with enhanced depth imaging optical coherence tomography in patients with mild Graves orbitopathy. Eye(Lond), 2016,30(7):917-924.
    \〖24\〗 Yu N, Zhang Y, Kang L, et al. Analysis in Choroidal Thickness in Patients with Graves' Ophthalmopathy Using Spectral-Domain Optical Coherence Tomography. J Ophthalmol, 2018, 2018: 3529395.
    \〖25\〗 Lai FHP, Iao TWU, Ng DSC, et al. Choroidal thickness in thyroid-associated orbitopathy. Clin Exp Ophthalmol, 2019,47(7):918-924.
    \〖26\〗 Yeter V, Koçak N, Suba瘙塂ı M, et al. Choroidal vascularity index in thyroid-associated ophthalmopathy. Can J Ophthalmol, 2023,58(1):27-33.
    \〖27\〗 Yu L, Jiao Q, Cheng Y, et al. Evaluation of retinal and choroidal variations in thyroid-associated ophthalmopathy using optical coherence tomography angiography. BMC Ophthalmol, 2020,20(1):421.
    \〖28\〗 Çalı瘙塂kan S, Acar M, Gürdal C. Choroidal Thickness in Patients with Graves' Ophthalmopathy. Curr Eye Res, 2017, 42(3): 484-490.
    \〖29\〗 Pehlivanoglu S, Aksoy FE, Karabulut GO, et al. Assessment of Choroidal Vascularity in Inactive Thyroid Associated Orbitopathy. Beyoglu Eye J, 2023, 8(1): 38-44.
    \〖30\〗 Casini G, Marinò M, Rubino M, et al. Retinal, choroidal and optic disc analysis in patients with Graves' disease with or without orbitopathy. Int Ophthalmol, 2020, 40(9): 2129-2137.
    \〖31\〗 Loiudice P, Pellegrini M, Marinò M, et al. Choroidal vascularity index in thyroid-associated ophthalmopathy: a cross-sectional study. Eye Vis(Lond), 2021, 8(1): 18.
    \〖32\〗 Ozturk Karabulut G, Fazil K, Ozturker C, et al. Do ocular pulse amplitude and choroidal thickness change in patients with thyroid eye disease? Orbit, 2019,38(5):347-352.
    \〖33\〗 Lim NC, Sundar G, Amrith S, et al. Thyroid eye disease: a Southeast Asian experience. Br J Ophthalmol, 2015,99(4):512-518.
    \〖34\〗 Torun IM, Dikmen NT, Unsal MA, et al. Evaluation of the choroidal vascular index and choroidal changes in migraine subgroups. Photodiagnosis Photodyn Ther, 2023,42:103348.
    \〖35\〗 Akpolat C, Kurt MM, Yılmaz M, et al. Analysis of Foveal and Parafoveal Microvascular Density and Retinal Vessel Caliber Alteration in Inactive Graves' Ophthalmopathy. J Ophthalmol, 2020, 2020: 7643737.
    \〖36\〗 Wang YH, Ma J, Li H, et al. Peripapillary and macular vessel density in eyes with different phases of thyroid-associated ophthalmopathy. Zhonghua Yan Ke Za Zhi, 2020,56(11):824-831.
    \〖37\〗 Ye L, Zhou SS, Yang WL, et al. RETINAL MICROVASCULATURE ALTERATION IN ACTIVE THYROID-ASSOCIATED OPHTHALMOPATHY. Endocr Pract, 2018, 24(7): 658-667.
    \〖38\〗 Mihailovic N, Lahme L, Rosenberger F, et al. ALTERED RETINAL PERFUSION IN PATIENTS WITH INACTIVE GRAVES OPHTHALMOPATHY USING OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY. Endocr Pract, 2020, 26(3): 312-317.
    \〖39\〗 Fazil K, Ozturk Karabulut G, Alkin Z. Evaluation of choroidal thickness and retinal vessel density in patients with inactive Graves' orbitopathy. Photodiagnosis Photodyn Ther, 2020,32:101898.
    \〖40\〗 Wu Y, Tu Y, Bao L, et al. Reduced Retinal Microvascular Density Related to Activity Status and Serum Antibodies in Patients with Graves' Ophthalmopathy. Curr Eye Res, 2020, 45(5): 576-584.
    \〖41\〗 Zhang X, Liu W, Zhang Z, et al. Analysis of macular blood flow changes in thyroid associated ophthalmopathy. BMC Ophthalmol, 2022, 22(1): 501.
    \〖42\〗 Zhang T, Xiao W, Ye H, et al. Peripapillary and Macular Vessel Density in Dysthyroid Optic Neuropathy: An Optical Coherence Tomography Angiography Study. Invest Ophthalmol Vis Sci, 2019, 60(6): 1863-1869.
    \〖43\〗 Yin S, Cui Y, Jiao W, et al. Quantitative Assessment Parameters of Peripapillary Regions with Branch Retinal Vein Occlusion by Using Optical Coherence Tomography Angiography. Biomed Res Int, 2022, 2022: 9281630.
    \〖44\〗 Mihailovic N, Eter N, Alnawaiseh M. Foveal avascular zone and OCT angiography. An overview of current knowledge. Ophthalmologe, 2019,116(7):610-616.
    \〖45\〗 Ceylanoglu KS, Sen EM, Doguizi S, et al. Smoking effect on peripapillary and macular microvascular structure in inactive Graves' ophthalmopathy. Int Ophthalmol, 2021,41(10):3411-3417.
    \〖46\〗 Kwapong WR, Gao Y, Yan Y, et al. Assessment of the outer retina and choroid in white matter lesions participants using swept-source optical coherence tomography. Brain Behav, 2021,11(8):e2240.
    \〖47\〗 Del Noce C, Vagge A, Nicolò M, et al. Evaluation of choroidal thickness and choroidal vascular blood flow in patients with thyroid-associated orbitopathy(TAO)using SD-OCT and Angio-OCT. Graefes Arch Clin Exp Ophthalmol, 2020, 258(5): 1103-1107.
    \〖48\〗 Del Noce C, Roda M, Ferro Desideri L, et al. Evaluation of macular blood flow after intermittent intravenous infusion of high-dose corticosteroids(pulse therapy)in patients with thyroid-associated orbitopathy(TAO)using angio-OCT. Graefes Arch Clin Exp Ophthalmol, 2022, 260(2): 571-576.
    \〖49\〗 Del Noce C, Roda M, Valsecchi N, et al. Evaluation of peripapillary vascular flow in patients with Thyroid-Associated Ophthalmopathy(TAO)by OCT Angiography. Graefes Arch Clin Exp Ophthalmol, 2022, 260(8): 2711-2716.
    Cited by
    Comments
    Comments
    分享到微博
    Submit
Get Citation

Guo Wei, Li Dongmei. ,/et al.Research progress of optical coherence tomography and optical coherence tomography angiography in thyroid-associated ophthalmopathy. Guoji Yanke Zazhi( Int Eye Sci) 2024;24(10):1576-1581

Copy
Share
Article Metrics
  • Abstract:119
  • PDF: 777
  • HTML: 0
  • Cited by: 0
Publication History
  • Received:December 28,2023
  • Revised:August 15,2024
  • Online: September 14,2024